Literature DB >> 923038

The effect of mannitol following permanent coronary occlusion.

H O Hirzel, E S Kirk.   

Abstract

Quantitative comparisons of infarcts 24 hours after ligation of the left anterior descending coronary artery (LAD) via thoracotomy were made in 13 control and 13 dogs treated with i.v. 25% mannitol, 2 ml/min for 4 hours following occlusion. Mannitol increased serum osmolarity by 44+/-4 mOsm/L (mean +/- 1 SE) with hemodynamic effects limited to a small increase in left ventricular dP/dt. Nonperfusible tissue measured by planimetry at 24 hours was similar in both groups (46+/-4% of area defined with dye injected into the distal LAD for control versus 48+/-5% for mannitol treated dogs, P = NS). Creatine phosphokinase activity in infarcted tissues was also similar in both groups. Myocardial blood flows measured with radioactive microspheres were also similar in both groups. Collateral conductance calcultaed from retrograde flow and aortic pressure increased with the 24 hour period by 146+/-23% in the control dogs; in the mannitol treated dogs, collateral increased only 38+/-14% (P less than 0.001). Thus mannitol had no effect on ultimate infarct size. Moreover, mannitol appeared to hinder the development of collateral vessels.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 923038     DOI: 10.1161/01.cir.56.6.1006

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  2 in total

1.  Intracoronary hyperosmotic mannitol during reperfusion does not affect infarct size in ischemic, reperfused porcine hearts.

Authors:  H H Klein; K Nebendahl; M Schubothe; H Kreuzer
Journal:  Basic Res Cardiol       Date:  1985 May-Jun       Impact factor: 17.165

2.  Abnormalities of volume regulation and membrane integrity in myocardial tissue slices after early ischemic injury in the dog: effects of mannitol, polyethylene glycol, and propranolol.

Authors:  L M Buja; J T Willerson
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.